aminocaproic acid has been researched along with Bernard-Soulier Syndrome in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Bernard-Soulier Syndrome: A familial coagulation disorder characterized by a prolonged bleeding time, unusually large platelets, and impaired prothrombin consumption.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ozelo, MC | 1 |
Svirin, P | 1 |
Larina, L | 1 |
Peng, TC | 1 |
Kickler, TS | 1 |
Bell, WR | 1 |
Haller, E | 1 |
2 other studies available for aminocaproic acid and Bernard-Soulier Syndrome
Article | Year |
---|---|
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Bernard-Soulier Syndrome; Epistaxis; | 2005 |
Obstetric complications in a patient with Bernard-Soulier syndrome.
Topics: Adult; Aminocaproic Acid; Bernard-Soulier Syndrome; Female; gamma-Globulins; Humans; Immunity, Mater | 1991 |